Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
NASDAQ:ENTX
Price:
2.51 USD
7.26%
Market Closed
Updated:
May 15, 2024
Entera Bio Ltd
Operating Expenses
|
Entera Bio Ltd
Operating Expenses Peer Comparison
Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Operating Expenses
-$8.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Operating Expenses
-$16.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Operating Expenses
-$45.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-7%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Operating Expenses
-$44.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Operating Expenses
-$138.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Operating Expenses
-₪32.9m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-13%
|
See Also
What is Entera Bio Ltd's Operating Expenses?
Operating Expenses
-8.9m
USD
-8.9m
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Operating Expenses amounts to -8.9m USD.
What is Entera Bio Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
5%
5%
Over the last year, the Operating Expenses growth was 32%. The average annual Operating Expenses growth rates for Entera Bio Ltd have been 7% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
